Marcello Moccia

InstitutionFederico II University
AddressNaples
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 2 publications in June 2020
    All Publications
    Bar chart showing 115 publications over 15 distinct years, with a maximum of 22 publications in 2016
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Di Filippo M, Cordioli C, Malucchi S, Annovazzi P, Cavalla P, Torri Clerici V, Ragonese P, Nociti V, Radaelli M, Laroni A, Buttari F, Lorefice L, Ferraro D, Gajofatto A, Prosperini L, Fantozzi R, Boffa L, Lanzillo R, Moccia M, Clerico M, De Luca G, Tomassini V, Calabrese M, Borrelli A, Paolicelli D, Maniscalco GT, Gazzola P, Gallo A, Solaro C, Cocco E, Gasperini C, Tortorella C. mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2021 Aug 18. PMID: 34408003.
      Citations: 3     Fields:    
    2. Carotenuto A, Scandurra C, Costabile T, Lavorgna L, Borriello G, Moiola L, Inglese M, Trojsi F, Petruzzo M, Ianniello A, Nozzolillo A, Cellerino M, Boffa G, Rosa L, Chiodi A, Servillo G, Moccia M, Bonavita S, Filippi M, Petracca M, Brescia Morra V, Lanzillo R. Physical Exercise Moderates the Effects of Disability on Depression in People with Multiple Sclerosis during the COVID-19 Outbreak. J Clin Med. 2021 Mar 16; 10(6). PMID: 33809698.
      Citations:    
    3. Capasso N, Palladino R, Montella E, Pennino F, Lanzillo R, Carotenuto A, Petracca M, Petracca M, Iodice R, Iovino A, Aruta F, Pastore V, Buonomo AR, Zappulo E, Gentile I, Triassi M, Brescia Morra V, Moccia M. Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg. J Clin Med. 2020 Dec 16; 9(12). PMID: 33339402.
      Citations: 6     
    4. Costabile T, Carotenuto A, Lavorgna L, Borriello G, Moiola L, Inglese M, Petruzzo M, Trojsi F, Ianniello A, Ianniello A, Nozzolillo A, Cellerino M, Boffa G, Rosa L, Servillo G, Moccia M, Bonavita S, Filippi M, Lanzillo R, Brescia Morra V, Petracca M, Petracca M. COVID-19 pandemic and mental distress in multiple sclerosis: Implications for clinical management. Eur J Neurol. 2021 Oct; 28(10):3375-3383. PMID: 33043560.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    5. De Angelis M, Petracca M, Petracca M, Lanzillo R, Brescia Morra V, Moccia M. Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice. Mult Scler Relat Disord. 2020 Oct; 45:102452. PMID: 32823148.
      Citations: 10     Fields:    Translation:HumansCellsPHPublic Health
    6. Miele G, Straccia G, Moccia M, Leocani L, Tedeschi G, Bonavita S, Lavorgna L. Telemedicine in Parkinson's Disease: How to Ensure Patient Needs and Continuity of Care at the Time of COVID-19 Pandemic. Telemed J E Health. 2020 12; 26(12):1533-1536. PMID: 32667839.
      Citations: 17     Fields:    Translation:HumansPHPublic Health
    7. Leocani L, Diserens K, Moccia M, Caltagirone C. Disability through COVID-19 pandemic: neurorehabilitation cannot wait. Eur J Neurol. 2020 09; 27(9):e50-e51. PMID: 32402100.
      Citations: 32     Fields:    
    8. Buonomo A, Brescia Morra V, Zappulo E, Lanzillo R, Gentile I, Montella E, Triassi M, Palladino R, Moccia M. COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peak. Mult Scler Relat Disord. 2020 Sep; 44:102282. PMID: 32554288.
      Citations: 7     Fields:    Translation:Humans
    9. Moccia M, Lanzillo R, Brescia Morra V, Bonavita S, Tedeschi G, Leocani L, Lavorgna L. Assessing disability and relapses in multiple sclerosis on tele-neurology. Neurol Sci. 2020 Jun; 41(6):1369-1371. PMID: 32440979.
      Citations: 29     Fields:    Translation:HumansCellsPHPublic Health